DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BLACK BOX WARNING ON PSYCHOTROPIC DRUG PRESCRIBING IN ELDERLY PATIENTS WITH DEMENTIA IN OUTPATIENT AND OFFICE-BASED SETTINGS
May 1, 2011, 00:00
10.1016/j.jval.2011.02.042
https://www.valueinhealthjournal.com/article/S1098-3015(11)00181-1/fulltext
Title :
DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BLACK BOX WARNING ON PSYCHOTROPIC DRUG PRESCRIBING IN ELDERLY PATIENTS WITH DEMENTIA IN OUTPATIENT AND OFFICE-BASED SETTINGS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00181-1&doi=10.1016/j.jval.2011.02.042
First page :
A7
Section Title :
Drug Use and Patient Safety
Open access? :
No
Section Order :
950